Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis
Md. Sahab Uddin, Md. Tanvir Kabir, Abdullah Al Mamun, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 4, pp. 2450-2465
Closed Access | Times Cited: 172

Showing 1-25 of 172 citing articles:

Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Stephen C. Cunnane, Eugenia Trushina, Cecilie Morland, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 9, pp. 609-633
Open Access | Times Cited: 676
Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer's disease
Elizabeta Zaplatić, Mohammed Hussen Bule, Syed Zahid Ali Shah, et al.
Life Sciences (2019) Vol. 224, pp. 109-119
Closed Access | Times Cited: 248
Oxidative stress in alzheimer’s disease: A review on emergent natural polyphenolic therapeutics
Luke Cassidy, Francesca Fernandez, Joel B. Johnson, et al.
Complementary Therapies in Medicine (2019) Vol. 49, pp. 102294-102294
Closed Access | Times Cited: 227
Combination Drug Therapy for the Management of Alzheimer’s Disease
Md. Tanvir Kabir, Md. Sahab Uddin, Abdullah Al Mamun, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3272-3272
Open Access | Times Cited: 160
Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
Yijun Chen, Yang Yu
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 143
Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer’s disease
Yuanming Li, Jing Zhang, Jiale Wan, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110887-110887
Open Access | Times Cited: 141
Neuroinflammation: A Potential Risk for Dementia
Md Afroz Ahmad, Ozaifa Kareem, Mohammad Khushtar, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 616-616
Open Access | Times Cited: 87
Energy metabolism in health and diseases
Hui Liu, Shuo Wang, Jianhua Wang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
Ramsey Najm, Emily A Aery Jones, Yadong Huang
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 137
Advancements in nanotherapeutics for Alzheimer’s disease: current perspectives
Seetha Harilal, Jobin Jose, Della Grace Thomas Parambi, et al.
Journal of Pharmacy and Pharmacology (2019) Vol. 71, Iss. 9, pp. 1370-1383
Open Access | Times Cited: 136
Autophagic dysfunction in Alzheimer’s disease: Cellular and molecular mechanistic approaches to halt Alzheimer’s pathogenesis
Md. Sahab Uddin, Abdullah Al Mamun, Zubair Khalid Labu, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 6, pp. 8094-8112
Closed Access | Times Cited: 132
Emerging promise of sulforaphane-mediated Nrf2 signaling cascade against neurological disorders
Md. Sahab Uddin, Abdullah Al Mamun, Md. Jakaria, et al.
The Science of The Total Environment (2019) Vol. 707, pp. 135624-135624
Closed Access | Times Cited: 132
Circadian and sleep dysfunction in Alzheimer’s disease
Md. Sahab Uddin, Devesh Tewari, Abdullah Al Mamun, et al.
Ageing Research Reviews (2020) Vol. 60, pp. 101046-101046
Closed Access | Times Cited: 128
Melatonin in Alzheimer’s Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer’s Neuropathology
Md. Farhad Hossain, Md. Sahab Uddin, G. M. Sala Uddin, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 12, pp. 8255-8276
Closed Access | Times Cited: 125
Estrogen Signaling in Alzheimer’s Disease: Molecular Insights and Therapeutic Targets for Alzheimer’s Dementia
Md. Sahab Uddin, M. M. Rahman, Md. Jakaria, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 6, pp. 2654-2670
Closed Access | Times Cited: 120
Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders
Eva Gil-Martins, Daniel José Barbosa, Vera Silva, et al.
Pharmacology & Therapeutics (2020) Vol. 213, pp. 107554-107554
Closed Access | Times Cited: 119
Resveratrol Derivatives as Potential Treatments for Alzheimer’s and Parkinson’s Disease
Bruno Dutra Arbo, Corinne André‐Miral, Raif Gregorio Nasre-Nasser, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 119
Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease
Md. Sahab Uddin, Md. Tanvir Kabir, Kamal Niaz, et al.
Molecules (2020) Vol. 25, Iss. 6, pp. 1267-1267
Open Access | Times Cited: 112
Emerging Signal Regulating Potential of Genistein Against Alzheimer’s Disease: A Promising Molecule of Interest
Md. Sahab Uddin, Md. Tanvir Kabir
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 107
Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning
Md. Tanvir Kabir, Md. Sahab Uddin, Mst. Marium Begum, et al.
Current Pharmaceutical Design (2019) Vol. 25, Iss. 33, pp. 3519-3535
Closed Access | Times Cited: 106
Nootropic and Anti-Alzheimer’s Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer’s Neuropathology
Md. Sahab Uddin, Abdullah Al Mamun, Md. Tanvir Kabir, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 7, pp. 4925-4944
Closed Access | Times Cited: 102
Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules
Seetha Harilal, Jobin Jose, Della Grace Thomas Parambi, et al.
Brain Research Bulletin (2020) Vol. 160, pp. 121-140
Closed Access | Times Cited: 101
Pharmacological approaches to mitigate neuroinflammation in Alzheimer’s disease
Md. Sahab Uddin, Md. Tanvir Kabir, Abdullah Al Mamun, et al.
International Immunopharmacology (2020) Vol. 84, pp. 106479-106479
Closed Access | Times Cited: 97
NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy
Md. Tanvir Kabir, Mohammad Abu Sufian, Md. Sahab Uddin, et al.
Current Pharmaceutical Design (2019) Vol. 25, Iss. 33, pp. 3506-3518
Closed Access | Times Cited: 95
Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer's disease
Md. Sahab Uddin, Md. Tanvir Kabir, Devesh Tewari, et al.
The Science of The Total Environment (2019) Vol. 700, pp. 134836-134836
Closed Access | Times Cited: 81
Page 1 - Next Page

Scroll to top